Pune (Maharashtra) [India], February 7 (ANI/PNN): The International School of Oncoplastic Surgery (ISOS) in association with BreastGlobal, Jehangir Hospital, and the University of East Anglia, UK recently concluded the highly successful Breast Oncology Workshop and Conference 2023. Held from
According to a study, CAR T-cell therapy, a type of cancer treatment in which the immune system's T cells are trained to attack tumour cells, is successful in mice with ovarian cancer.
Some cancers respond well to immunotherapy, a medication therapy that prompts the immune system to target tumours, although results against lung cancer have been conflicting.
The presence of a brain tumour can be determined by identifying a crucial membrane protein in urine, according to research from Nagoya University in Japan. By eliminating the need for intrusive tests and raising the possibility that tumours are found early enough for surgery, their protein m
The source of tumour cell resistance to immunotherapy was identified by a recent study that examined the pancreatic cancer tumour microenvironment, and novel therapeutic approaches were developed as a result.
Hormone Replacement Therapy (HRT) could help prevent Alzheimer's Dementia among women at risk of developing the disease, according to University of East Anglia research.
Chemotherapy and pembrolizumab have been approved for the treatment of women with metastatic, recurring, or persistent cervical cancer whose tumours express PD-L1. Chemotherapy can be administered with or without bevacizumab. Whether pembrolizumab in this combination provides patients with a
Researchers have uncovered a gene that is overexpressed in mutated IDH1. Studies in human cells and a novel mouse model both show that this gene, called ZMYND8, plays a critical role in radiation resistance. When they knocked down the gene, the glioma cells became responsive to radiation tre
Researchers revealed that Immunotherapies have improved the outcomes of many cancer patients, including those with melanoma. However, only a subset of patients benefit from these treatments.
Researchers with the SFU Nanodevice Fabrication Group are developing a new biosensor that can be used to screen for Alzheimer's disease and other diseases. An overview of their work has been recently published in the journal Nature Communications.